Asia Pacific Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)

BMIRE00028461 | Pages: 158 | Biotechnology | May 2023 | Type: Regional | Status: Published

The Asia Pacific blood plasma derivatives market was valued at US$ 6,324.33 million in 2022 and is projected to reach US$ 11,118.43 million by 2028; it is expected to grow at a CAGR of 9.9% from 2022 to 2028. 

Incorporation of Platelet-Rich Plasma in Regenerative Medicine is Driving the Asia Pacific Blood Plasma Derivatives Market

The cases of peripheral nerve injury (PNI) are rising, and the slow regeneration process in PNI patients leads to loss of nerve functions. In addition, research on the mechanism of peripheral nerve regeneration has accelerated significantly, and researchers are seeking different methods to enhance peripheral nerve regeneration. Platelets-rich protein (PRP) therapy integrates mainstream technologies for repairing and rejuvenating the tissues damaged due to injury or chronic diseases. PRP injections have improved regenerative medicine treatments for wound healing, skin regeneration, cosmetic and plastic surgery, and orthopedic procedures in the past few years.

Evidence has shown that micro-needling (MN) and topical application, along with PRP, improve collagen production and skin tightening for vampire facials. According to the report "Combined micro needling with topical application of platelet-rich plasma versus micro-needling alone in the treatment of stria distensae" published in 2020, MN-PRP was associated with an excellent improvement of skin lesions of Striae distensae (SD), more significant deposition of collagen and elastic fibers, increased proliferative activity in epidermis, and decreased caspase-3 protein expression values in epidermis. It has also been used to treat skin pigmentation disorders and acne scars. In hair transplants, PRP can bind to growth factors and elevates the proliferation of human derma papilla cells leading to the formation and maintenance of hair follicles. PRP injections are gaining popularity for treating various conditions, from sports injuries to hair loss. PRP can be widely used in regenerative medicines owing to its tissue regeneration capability, which is likely to provide lucrative opportunities for the blood plasma derivatives market in the coming years. 

Asia Pacific Blood Plasma Derivatives Market Overview 

Asia Pacific blood plasma derivatives market has been segmented into the China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China is expected to account for the largest market share and is expected to develop moderately in the Asia Pacific.

The factors evaluated to impact the growth of the market are the increasing number of organizations that ensure the supply of blood plasma, along with the presence of countries that are major contributors in terms of market growth aspects of the region. In China, there is wide use of blood plasma for various treatments, and the country is making huge contributions to the blood plasma market in the Asia Pacific region. China also accounted for many fractionation facilities, the highest in the Asia Pacific region. The country encompasses lucrative opportunities in terms of novel plasma therapy production. The hospital industry of the country is recording rapid growth due to advanced healthcare reforms. According to an article, the country is one of the largest manufacturers or consumers in the plasma-derived product market.

Asia Pacific Blood plasma derivatives Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Asia Pacific Blood plasma derivatives Market Segmentation

The Asia Pacific blood plasma derivatives market is segmented into type, application, end user, and country.

The Asia Pacific blood plasma derivatives market, by type, is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held a larger market share in 2022. 

Based on application, the Asia Pacific blood plasma derivatives market is divided into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand disease, and other applications. The immunodeficiency diseases applications segment held the largest share of the market in 2022.

The blood plasma derivatives market, by end user, is segmented into hospitals, diagnostic laboratories, clinics, and other end users. The hospitals segment held the largest share of the market in 2022. 

Based on country, the Asia Pacific blood plasma derivatives market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022.

Grifols SA; SK Plasma Co Ltd; Octapharma AG; Monobind Inc.; Intas Pharmaceuticals Ltd; Takeda Pharmaceutical Co Ltd; CSL Behring LLC; LFB SA; Kedrion SpA; and Fusion Health Care Pvt Ltd are the leading companies operating in the Asia Pacific blood plasma derivatives market.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Blood Plasma Derivatives Market – by Type

1.3.2        Asia Pacific Blood Plasma Derivatives Market – by Application

1.3.3        Asia Pacific Blood Plasma Derivatives Market – by End User

1.3.4        Asia Pacific Blood Plasma Derivatives Market – by Country

2.           Asia Pacific Blood Plasma Derivatives Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Blood Plasma Derivatives Market – Market Landscape

4.1         Overview

4.2         Asia Pacific PEST Analysis

4.3         Expert’s Opinion

5.           Asia Pacific Blood Plasma Derivatives Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increase in Prevalence of Blood Disorders

5.1.2        Rise in Geriatric Population

5.2         Market Restraints

5.2.1        Complicated Reimbursement Policies

5.3         Market Opportunities

5.3.1        Incorporation of Platelet-Rich Plasma in Regenerative Medicine

5.4         Future Trends

5.4.1        Increasing Usage of Immunoglobulin G in Multiple Treatments

5.5         Impact Analysis

6.           Blood Plasma Derivatives Market – Asia Pacific Analysis

6.1         Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.           Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by Type

7.1         Overview

7.2         Asia Pacific Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)

7.3         Albumin

7.3.1        Overview

7.3.2        Albumin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Factor VIII

7.4.1        Overview

7.4.2        Factor VIII: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Factor IX

7.5.1        Overview

7.5.2        Factor IX: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Immunoglobulin

7.6.1        Overview

7.6.2        Immunoglobulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.3        IgG

7.6.3.1          Overview

7.6.3.2          IgG: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.4        IgM

7.6.4.1          Overview

7.6.4.2          IgM: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.5        IgA

7.6.5.1          Overview

7.6.5.2          IgA: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.6        IgD

7.6.6.1          Overview

7.6.6.2          IgD: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.7        IgE

7.6.7.1          Overview

7.6.7.2          IgE: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Hyperimmune Globulin

7.7.1        Overview

7.7.2        Hyperimmune Globulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.8         Others

7.8.1        Overview

7.8.2        Others: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Blood Plasma Derivatives Market Analysis and Forecasts to 2028 – by Application

8.1         Overview

8.2         Asia Pacific Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)

8.3         Hemophilia

8.3.1        Overview

8.3.2        Hemophilia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Hypogammaglobulinemia

8.4.1        Overview

8.4.2        Hypogammaglobulinemia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Immunodeficiency Diseases

8.5.1        Overview

8.5.2        Immunodeficiency Diseases: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Von Willebrand Disease

8.6.1        Overview

8.6.2        Von Willebrand Disease: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Other Applications

8.7.1        Overview

8.7.2        Other Applications: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by End User

9.1         Overview

9.2         Asia Pacific Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Other End Users

9.5.1        Overview

9.5.2        Other End Users: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – Country Analysis

10.1      Overview

10.1.1     Asia Pacific: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)

10.1.1.1       Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Australia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.1.3.1     Australia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.1.4       Australia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.1.5       Australia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.2       China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       China: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.2.3.1     China: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.2.4       China: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.2.5       China Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.3       India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       India: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.3.3.1     India: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.3.4       India: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.3.5       India Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.4       Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       Japan: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.4.3.1     Japan: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.4.4       Japan: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.4.5       Japan Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.5       South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Overview

10.1.1.5.2       South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3       South Korea: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.5.3.1     South Korea: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.5.4       South Korea: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.5.5       South Korea Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.6       Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Asia Pacific: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.6.3.1     Rest of Asia Pacific: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.6.4       Rest of Asia Pacific: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.6.5       Rest of Asia Pacific Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Growth Strategies in the Blood Plasma Derivatives Market

11.3      Inorganic Growth Strategies

11.3.1     Overview

11.4      Organic Growth Strategies

11.4.1     Overview

12.        Company Profiles

12.1      Grifols SA

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      SK Plasma Co Ltd

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Octapharma AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Monobind Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Intas Pharmaceuticals Ltd

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Fusion Health Care Pvt Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Takeda Pharmaceutical Co Ltd

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      CSL Behring LLC

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      LFB SA

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Kedrion SpA

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

LIST OF TABLES

Table 1.             Australia Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Australia Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Australia Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Australia Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.             China Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             China Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 7.             China Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             China Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9.             India Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          India Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 11.          India Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12.          India Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Japan Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Japan Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Japan Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Japan Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17.          South Korea Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 18.          South Korea Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 19.          South Korea Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 20.          South Korea Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Rest of Asia Pacific Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Rest of Asia Pacific Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Rest of Asia Pacific Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of Asia Pacific Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market

Table 26.          Recent Organic Growth Strategies in the Blood Plasma Derivatives Market

Table 27.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Asia Pacific Blood Plasma Derivatives Market Segmentation

Figure 2.           Asia Pacific Blood Plasma Derivatives Market, by Country

Figure 3.           Asia Pacific Blood Plasma Derivatives Market Overview

Figure 4.           Immunoglobulin Segment Held Largest Share of Type Segment in Asia Pacific Blood Plasma Derivatives Market

Figure 5.           India is Expected to Show Remarkable Growth During Forecast Period

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           Asia Pacific Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        Asia Pacific Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)

Figure 11.        Albumin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Factor VIII: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Factor IX: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Immunoglobulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        IgG: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        IgM: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        IgA: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        IgD: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        IgE: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Hyperimmune Globulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Asia Pacific Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)

Figure 23.        Hemophilia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Hypogammaglobulinemia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Immunodeficiency Diseases: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Von Willebrand Disease: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Other Applications: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Asia Pacific Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)

Figure 29.        Hospitals: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Clinics: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Other End Users: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Asia Pacific: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)

Figure 33.        Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Growth Strategies in the Blood Plasma Derivatives Market

 

  1. Grifols SA
  2. SK Plasma Co Ltd
  3. Octapharma AG
  4. Monobind Inc.
  5. Intas Pharmaceuticals Ltd
  6. Takeda Pharmaceutical Co Ltd
  7. CSL Behring LLC
  8. LFB SA
  9. Kedrion SpA
  10. Fusion Health Care Pvt Ltd
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific blood plasma derivatives market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific blood plasma derivatives market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the blood plasma derivatives market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000